mathematical modelling

A new study has shown that maths and medicine could help cure patients suffering from CML or chronic myelogenous leukaemia with an optimally-timed cancer vaccine, where the timing is determined based on their own immune response.Researchers have described their success in creating a mathematical model which predicts that anti-leukaemia immune response in CML patients using the drug imatinib can actually be stimulated in a way to provide a cure for the disease.In their study,the researchers took into account the patient's natural immune response in conjunction with effects of imatinib, a drug that has been successful in putting CML patients into remission.They wanted to see if they can develop a mathematical model, or set of rules, that increases chances for long-term remission in individual patients.